Clinical Trial Update: A Trial of HRS-5965 Tablets in Primary IgA Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial of HRS-5965 for IgA nephropathy is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• HRS-5965

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Primary IgA Nephropathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING